Jia Zhou, PhD
Affiliations: | University of Texas Medical Branch, Galveston, TX |
Area:
Medicinal ChemistryWebsite:
https://scmm.utmb.edu/faculty/f_zhou.aspGoogle:
"Jia Zhou"Bio:
My research interests are broadly based on the interface of synthetic organic chemistry and medicinal chemistry, and in particular on the drug discovery of bioactive molecules to probe biological systems or act as potential therapeutic agents in neuroscience, cancer/inflammation, infectious diseases, and other human conditions.
- https://scmm.utmb.edu/faculty/f_zhou.asp
Mean distance: (not calculated yet)
Parents
Sign in to add mentorRuyu Chen | grad student | 1994-1997 | |
Sidney M. Hecht | post-doc | 1999-2001 | |
Alan P. Kozikowski | post-doc | 2001-2003 |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Murphy RE, Wang P, Ali S, et al. (2024) Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists. Journal of Medicinal Chemistry |
Chen J, Garcia EJ, Merritt CR, et al. (2023) Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT Receptor and Dual 5-HT/5-HT Receptor Modulators. Journal of Medicinal Chemistry |
Xu J, Shi S, Liu G, et al. (2022) Design, synthesis, and pharmacological evaluations of pyrrolo[1,2-a]quinoxaline-based derivatives as potent and selective sirt6 activators. European Journal of Medicinal Chemistry. 246: 114998 |
Liu Z, Li Y, Chen H, et al. (2022) Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. Journal of Medicinal Chemistry |
Liu Z, Wang P, Wold EA, et al. (2021) Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer. Journal of Medicinal Chemistry |
Xu J, Berastegui-Cabrera J, Carretero-Ledesma M, et al. (2021) Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome. International Journal of Molecular Sciences. 22 |
Ye N, Qin W, Tian S, et al. (2020) Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. Journal of Medicinal Chemistry |
Li Z, Xu J, Lang Y, et al. (2020) JMX0207, a niclosamide derivative with improved pharmacokinetics, suppresses Zika virus infection both in vitro and in vivo. Acs Infectious Diseases |
Zhou Z, Li X, Liu Z, et al. (2020) A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression. Frontiers in Pharmacology. 11: 1043 |
Dvorak NM, Wadsworth PA, Wang P, et al. (2020) Bidirectional Modulation of the Voltage-Gated Sodium (Nav1.6) Channel by Rationally Designed Peptidomimetics. Molecules (Basel, Switzerland). 25 |